FTC Approves Final Order Preserving Future Competition in Generic Injectable Tuberculosis Drug Market

Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Akorn, Inc.’s acquisition of VersaPharm Inc. and its parent company, VPI Holdings Corp., would have likely been anticompetitive. Under the order, first announced in August 2014, Akorn is required to divest its Abbreviated New Drug Application for generic […]

Appeals Court Affirms Ruling in Favor of FTC, Upholds $163 Million Judgment Against ‘Scareware’ Marketer

In a victory for the Federal Trade Commission in its efforts to protect consumers from spyware and malware, a federal appeals court has upheld a district court ruling that imposed a judgment of more than $163 million on Kristy Ross for her role in an operation that used computer “scareware” to trick consumers into thinking […]